Chart is not available for J K Pharmachem Ltd. Please visit after some time.
Meanwhile check Top Gainers - bse for today here: Top Gainers bse
J K Pharmachem Ltd Overview
Fundamentals of J K Pharmachem Ltd
|P/E Ratio (TTM)||NA|
|Debt to Equity||NA|
Financials of J K Pharmachem Ltd
Financials data is not available for J K Pharmachem Ltd. Please visit after some time.
About J K Pharmachem Ltd
Jointly promoted by J K Industries and TIDCO, J K Pharmachem manufactures drugs and pharmaceuticals. It entered the capital market in Oct.'94 to part-finance the setting up of a plant to manufacture 1 ... 250 MMU P.a of pencillin-G, based on a microbial strain from the technical collaborators -- IGC (Cyprus), Cyprus -- a wholly-owned subsidiary of ICN Galenika. Commercial production at this plant commenced in Oct.'95. The company has a tie-up with ICN Galenika, part of the ICN Pharmaceuticals group (one of the pioneering manufacturers of pencillin-G), to set up a 1250-mmu capacity plant. It has already produced international standard penicillin with Indian raw materials, at its collaborator's plant which is among the best in the world. In addition, J K Pharmachem had set-up its own R&D activity well in advance for future development in the field of bio-technology. A pilot plant is also being established for this purpose at Cuddalore, Tamilnadu. The company also plans to diversify into speciality fermentation products. It has also started production of Penicillin-V and is the only one in India to produce this bulk active. During 1999-2000, the company started the production of Penicillin V and is the only producer of this important bulk active in India. The accumulated losses of the company having exceeded 50% of the peak networth of the company in the immediately preceding four financial years, the company took the necessary steps of SICA, 1985. The company developed an in-house and launched viz JKZyme, an environment new product of paper & pulp. Commercial trails are under way in India and abroad. The company has produced 1192 MMU of Penicillin-G during the financial year 2003-04 and retained its status as the second largest producer with a market share of 24%. Read More
|Stocks||Market Cap (cr)||Market Price (₹)||52 Week Low-High (₹)|
|Supriya Lifescience Ltd||₹2,053.92||
|250.1 - 257.1|
|Celestial Biolabs Ltd||₹4.56||
|1.75 - 1.8|
|JFL Life Sciences Ltd||₹41.79||
|40.9 - 40.9|
|Procter & Gamble Health Ltd||₹8,663.96||
|5178.1 - 5316.9|
|Veerhealth Care Ltd||₹26.17||
|26 - 26|
What is the Share price of J K Pharmachem Ltd (JKPHARMA)?
Can I buy J K Pharmachem Ltd (JKPHARMA) shares?
How do I buy J K Pharmachem Ltd (JKPHARMA) from Angel One?
- Direct investment: You can buy J K Pharmachem Ltd (JKPHARMA) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to J K Pharmachem Ltd (JKPHARMA) shares.